THE EFFICACY AND SAFETY OF SODIUM-GLUCOSE COTRANSPORTER 2 (SGLT2) INHIBITORS: A SYSTEMATIC REVIEW AND META-ANALYSIS

被引：0
|
作者：
Alves, C. [1 ,2 ]
Penedones, A. [1 ]
Mendes, D. [1 ,2 ]
Batel Marques, F. [1 ,2 ]
机构：
[1] AIBILI Assoc Innovat & Biomed Res Light & Image, CHAD Ctr Hlth Technol Assessment & Drug Res, Coimbra, Portugal
[2] Univ Coimbra, Sch Pharm, Coimbra, Portugal
来源：
CLINICAL THERAPEUTICS | 2015年 / 37卷 / 08期
关键词：
D O I：
10.1016/j.clinthera.2015.05.352
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：E123 / E124
页数：2
相关论文
共 50 条
  • [21] Sodium-glucose cotransporter 2 (SGLT2) inhibitors and fracture risk in patients with type 2 diabetes mellitus: A meta-analysis
    Ruanpeng, Darin
    Ungprasert, Patompong
    Sangtian, Jutarat
    Harindhanavudhi, Tasma
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2017, 33 (06)
  • [22] Efficacy and safety of sodium-glucose cotransporter-2 inhibitors in patients with chronic kidney disease: a systematic review and meta-analysis
    Shiau, Chu-Hsuan
    Tsau, Li-Yun
    Kao, Chih-Chin
    Peng, Yu-Ching
    Bai, Chyi-Huey
    Wu, Jeng-Cheng
    Hou, Wen-Hsuan
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2024, 56 (04) : 1359 - 1381
  • [23] Efficacy and safety of sodium-glucose cotransporter-2 inhibitors in patients with chronic kidney disease: a systematic review and meta-analysis
    Chu-Hsuan Shiau
    Li-Yun Tsau
    Chih-Chin Kao
    Yu-Ching Peng
    Chyi-Huey Bai
    Jeng‑Cheng Wu
    Wen-Hsuan Hou
    International Urology and Nephrology, 2024, 56 : 1359 - 1381
  • [24] The Safety and Efficacy of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors in Acute Myocardial Infarction: A Systematic Review and MetaAnalysis of Randomized Controlled Trials
    Jafar, Uzair
    Khan, Muhammad Sami
    Hashmi, Tallal Mushtaq
    Ijaz, Maryam
    Jehangir, Hanzala
    Jagani, Sanjna Devi
    Munawar, Irja
    Khalid, Ayesha
    Maqsood, Maham
    Akram, Muhammad Faiq
    Saeed, Usman
    Ahmad, Adeel
    CIRCULATION, 2024, 150
  • [25] Bexagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, for improvement of glycemia in type 2 diabetes mellitus: a systematic review and meta-analysis
    Dholariya, Sagar
    Dutta, Siddhartha
    Singh, Ragini
    Parchwani, Deepak
    Sonagra, Amit
    Kaliya, Mehul
    EXPERT OPINION ON PHARMACOTHERAPY, 2023, 24 (18) : 2187 - 2198
  • [26] Comparative safety of the sodium glucose co-transporter 2 (SGLT2) inhibitors: a systematic review and meta-analysis
    Donnan, Jennifer R.
    Grandy, Catherine A.
    Chibrikov, Eugene
    Marra, Carlo A.
    Aubrey-Bassler, Kris
    Johnston, Karissa
    Swab, Michelle
    Hache, Jenna
    Curnew, Daniel
    Hai Nguyen
    Gamble, John-Michael
    BMJ OPEN, 2019, 9 (01):
  • [27] Efficacy and safety of SGLT2 inhibitors in heart failure: systematic review and meta-analysis
    Butler, Javed
    Usman, Muhammad Shariq
    Khan, Muhammad Shahzeb
    Greene, Stephen J.
    Friede, Tim
    Vaduganathan, Muthiah
    Filippatos, Gerasimos
    Coats, Andrew J. Stewart
    Anker, Stefan D.
    ESC HEART FAILURE, 2020, 7 (06): : 3298 - 3309
  • [28] Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors: Benefits Versus Risk
    Jasleen, Bains
    Vishal, Gupta K.
    Sameera, Malepati
    Fahad, Molla
    Brendan, O'Brien
    Deion, Santander
    Pemminati, Sudhakar
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (01)
  • [29] REVIEW OF EFFICACY AND SHORT TERM SAFETY OF SODIUM-GLUCOSE COTRANSPORTER 2 (SGLT2) INHIBITORS USE IN DIABETIC RENAL TRANSPLANT RECIPIENTS
    AlKindi, Fatima
    Chaaban, Ahmad
    AlHakim, Mohammed
    Hussain, Qutaiba
    Boobes, Yousef
    TRANSPLANTATION, 2020, 104 (09) : S384 - S384
  • [30] Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors: Harms or Unexpected Benefits?
    Andreea, Munteanu Madalina
    Surabhi, Swarnkar
    Razvan-Ionut, Popescu
    Lucia, Ciobotaru
    Camelia, Nicolae
    Emil, Tufanoiu
    Tiberiu, Nanea Ioan
    MEDICINA-LITHUANIA, 2023, 59 (04):
12345